Biologic therapeutics as the fourth modality in cancer treatment
Masucci, G.; Mellstedt, H.
Leukemia 4(2): 81-82
1990
ISSN/ISBN: 0887-6924 PMID: 2406519 Document Number: 352345
Document emailed within 1 workday
Related Documents
Larsen, C.M.; Mandrup-Poulsen, T. 2008: Treatment of diabetes mellitus with biologic therapeutics Ugeskrift for Laeger 170(24): 2134-2137Urba, S. 1997: Combined-modality treatment of esophageal cancer Oncology 11(9 Suppl 9: 63-67
Porschen, R. 1993: Perioperative multi-modality treatment strategies in esophageal cancer Zeitschrift für Gastroenterologie 31(11): 680-685
Willett, C.G.; Clark, J.W. 2003: Update on combined-modality treatment options for pancreatic cancer Oncology 17(12 Suppl. 13): 29-36
Trovò, M.G.; Gigante, M.; Minatel, E.; Gobitti, C.; Franchin, G. 1998: Combined modality treatment of locally advanced lung cancer Tumori 84(2): 259-269
Minsky, B.D. 2006: Choosing the correct modality for the treatment of dysphagia in the patient with esophageal cancer Journal of Supportive Oncology 4(8): 377
Perng, R.P.; Chien, K.Y.; Chen, K.Y. 1989: Combined modality treatment for non-small cell lung cancer. Lung Cancer Study Group Zhonghua Yi Xue Za Zhi 43(4): 217-222
Hoekstra, C.J.; Rijna, H.; Smit, E.F.; Van Mourik, J.C.; Postmus, P.E.; Lammertsma, A.A.; Hoekstra, O.S. 2002: Failure patterns of combined modality treatment in lung cancer: the impact of staging Netherlands Journal of Medicine 60(1): 17-21
Holland, J.F.; Ohnuma, T. 1981: Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators Cancer Treatment Reports 65(Suppl 4): 123-130
Herber, D.L. 2007: Molecular Targets in Cancer Therapy - Fourth Biennial Meeting. Mechanism and therapeutic reversal of immune suppression in cancer IDrugs: the investigational drugs journal 10(4): 227-229
Abadir, R. 1979: Hyperthermia. a modality of cancer therapy Missouri Medicine 76(11): 581-584
DeVita, V.T. 1983: Advances in cancer therapeutics: chemotherapy Progress in Clinical and Biological Research 132a: 47-69
Cho, L.C.; Choy, H. 2004: Topoisomerase i inhibitors in the combined-modality therapy of lung cancer Oncology 18(7 Suppl 4: 29-39
Minsky, B.D. 1999: Adjuvant postoperative combined-modality therapy for rectal cancer Oncology 13(7 Suppl 3: 132-135
Wehrlin, N. 1983: Therapeutics: hormone therapy for breast cancer Revue de l'Infirmiere 33(11): 35-38
Felgner, P.L.; Zaugg, R.H.; Norman, J.A. 1995: Synthetic recombinant DNA delivery for cancer therapeutics Cancer Gene Therapy 2(1): 61-65
Brissette, R.; Prendergast, J.K.A.; Goldstein, N.I. 2006: Identification of cancer targets and therapeutics using phage display Current Opinion in Drug Discovery and Development 9(3): 363-369
Wang, D.Y.; Sosman, J.A.; Johnson, D.B. 2015: Combination Immunotherapy: An Emerging Paradigm in Cancer Therapeutics Oncology 29(12): 1005-1006
Shen, Y. 2008: Advances in the development of siRNA-based therapeutics for cancer Idrugs: the Investigational Drugs Journal 11(8): 572-578
Cowan, K.; Lippman, M. 1981: Recent progress in breast cancer management. Combined modality (adjuvant) therapy Archives of Internal Medicine 141(8): 1055-1059